AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $81,000 | -34.7% | 10,659 | -33.6% | 0.00% | -33.3% |
| Q3 2019 | $124,000 | -67.2% | 16,061 | -70.9% | 0.00% | -62.5% |
| Q2 2019 | $378,000 | +182.1% | 55,116 | +231.3% | 0.01% | +166.7% |
| Q1 2019 | $134,000 | -60.4% | 16,637 | -53.1% | 0.00% | -57.1% |
| Q3 2018 | $338,000 | -62.4% | 35,447 | -58.0% | 0.01% | -58.8% |
| Q2 2018 | $899,000 | +945.3% | 84,315 | +372.9% | 0.02% | +750.0% |
| Q3 2017 | $86,000 | +79.2% | 17,831 | +43.8% | 0.00% | +100.0% |
| Q2 2017 | $48,000 | – | 12,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |